HTS Calcium Flux Assay

GS Gregory Sliwoski
MS Mario Schubert
JS Jan Stichel
DW David Weaver
AB Annette G. Beck-Sickinger
JM Jens Meiler
request Request a Protocol
ask Ask a question
Favorite

The purities of compounds in the Vanderbilt HTS facility are more than 95% as confirmed by the supplier. A total of 35,288 compounds were tested for their ability to modulate the Y4R activation in conjunction with the Vanderbilt HTS facility. In a pilot HTS experiment, 2000 compounds (spectrum collection, MicroSource Discovery Systems, Inc., Gaylordsville, CT) were screened for modulation of the Y4R. This collection is designed to enrich the general hit rate by including drugs with known biological profiles (60%), naturally occurring products with no biological profile (25%), and non-drug compounds with biological profiles (15%). In a following HTS, 33,288 compounds were tested for Y4R modulatory effects. Thirty-two thousand of these compounds were randomly selected from the Vanderbilt compound library and 1288 were selected based on their similarity to Niclosamide, a PAM discovered in the pilot HTS.

Cells were plated in TC-treated 384-well plates (black, clear bottom, Greiner, Monroe, NC) in 20 μL cell culture medium using a Multidrop Combi (Thermo Fisher, Waltham, MA) microplate dispenser (ThermoScientific, Thermo Fisher) at a density of 16,000 cells/well. The cells were incubated for 24 hours at 37°C in the presence of 5% CO2. Following incubation, the medium was replaced with 20 μL/well fluorescent dye solution (1.0 μM Fluo-2 AM (TEFlabs, Austin, TX), .01% (v/v) Pluronic Acid F-127 in assay buffer) using an ELx405 cell washer (BioTek, Winooski, VT). Following a 90 minute incubation at room temperature, fluorescent dye solution was replaced with 20 μL/well assay buffer (HBSS, 20 mM HEPES, and 1.25 mM Probenecid (Sigma-Aldrich, St. Louis, MO)) using the ELx405 and cell plates were loaded into a Functional Drug Screening System (FDSS, Hamamatsu, Japan). Once loaded into the FDSS, cell plates were imaged at 1Hz (excitation 470 ± 20 nm, emission 540 ± 30 nm using a 3-addition protocol designed to detect agonists, potentiators, and inhibitors: 1) after collecting 4 seconds of baseline, 20 μl/well of 20 μM test compounds in assay buffer + 0.1% (w/v) fatty-acid-free bovine serum albumin (Sigma-Aldrich, modified assay buffer) were added 2) following a 150 second delay, 10 μl/well of concentration of 5-fold over the PP EC20 (55 ± 27 pM) 3) after 330 seconds, a 13 μl/well addition 5-fold over the PP EC80 (836 ± 33 pM) in modified assay buffer was performed. On each screening day, PP EC20 and EC80 plates were adjusted after a test PP CRC at the beginning of each day to account for minor day to day variations in experimental conditions.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A